Recent Company News

• 04:53 PM ET May 14, 2025
  

  Akari Therapeutics reports Q1 GAAP EPS $0.00 vs year-ago $0.00 - 10-Q ($1.35, 0.00)

• 04:36 PM ET Apr 15, 2025
  

  Akari Therapeutics reports FY EPS $0.00 vs year-ago $0.00 - 10-K ($1.20, 0.00)

• 08:40 AM ET Mar 20, 2025
  

  Akari Therapeutics appoints Abizer Gaslightwala as President and CEO, effective 21-Apr ($1.25, 0.00)

• 09:06 AM ET Mar 03, 2025
  

  Akari Therapeutics announces $7.6M private placement ($0.87, 0.00)

• 08:55 AM ET Dec 18, 2024
  

  Akari Therapeutics announced appointment of Samir R. Patel, M.D., as CEO ($1.00, 0.00)

• 09:06 AM ET Dec 16, 2024
  

  Akari Therapeutics appoints Torsten Hombeck as CFO; effective 16-Dec ($0.97, 0.00)

• 04:34 PM ET Dec 12, 2024
  

  Akari Therapeutics to appoint Samir Patel as interim CFO; effective 12-Dec-24 - 8-K ($0.95, 0.00)

• 04:58 PM ET Nov 19, 2024
  

  Akari Therapeutics reports Q3 GAAP EPS $0.00 vs year-ago $0.00 - 10-Q ($1.57, 0.00)

• 09:10 AM ET Nov 19, 2024
  

  Akari Therapeutics regains full NASDAQ compliance ($2.29, 0.00)

• 04:26 PM ET Nov 14, 2024
  

  Akari Therapeutics announces successful completion of merger of Akari Therapeutics and Peak Bio ($2.23, 0.00)